期刊文献+

高效液相色谱法测定扎那米韦含量及有关物质 被引量:1

HPLC determination of zanamivir content and the related substances
原文传递
导出
摘要 目的:建立测定扎那米韦的含量和有关物质的高效液相方法。方法:采用NH2P-50色谱柱(250 mm×4.6 mm,5μm),流动相为乙腈-5 mmol·L^(-1)硫酸溶液(60∶40)[用氨水调节pH至(6.2±0.05)];检测波长为234和210 nm;流速为1.0 mL·min^(-1),柱温为30℃。同时采用液质联用对各杂质进行了结构确证。结果:主药与各杂质、各杂质之间分离度良好,各杂质能有效检出。在100.10~1 001.0μg·mL^(-1)浓度范围内,扎那米韦与其峰面积呈良好的线性关系(r=0.999 9,n=5),最小检测限为25.0 ng·mL^(-1),含量测定及有关物质检查的中间精密度RSD分别为0.24%(n=6)与1.24%(n=6)。结论:本法简便、精密、专属、灵敏,可用于扎那米韦含量和有关物质测定。 Objective: To develop an HPLC method for simultaneously determining zanamivir content and its related substances for quality control. Methods: The method was performed on an Asahipak NH2P-50 column ( 250 mm x 4.6 mm, 5 Ixm) with acetonitrile-5 mmol. L - 1 sulphuric acid (60: 40) [ adjusting pH to (6.2 ± 0.05 ) with ammonia solution ] as the mobile phase. The flow rate was 1.0 mL· min-l. The detection wavelength was 234 and 210 nm, and the column temperature was set at 30 ℃. Meanwhile, the structure of each impurity was confirmed by LCMS. Results: Zanamivir was completely separated from the related substances. The calibration curve of zanamivir was linear ( r = 0. 999 9, n = 5 ) in the range of 100.10 ± 1 001.0 μg·mL^(-1) ; detection limit was 25.0 μg·mL^(-1) the intermediate precisions RSD were 0.24% and 1.24% (n =6) in the content and related substance determination. Conclusion: The method is simple, accurate, specific and sensitive for simultaneously determining the content and its related substances of zanamivir.
出处 《中国新药杂志》 CAS CSCD 北大核心 2018年第1期31-37,共7页 Chinese Journal of New Drugs
基金 国家"重大新药创制"科技重大专项资助项目(2014ZX09507005004) 国家自然科学基金面上项目(81273464 81473146)
关键词 扎那米韦 含量 有关物质 高效液相色谱 zanamivir content related substances HPLC
  • 相关文献

参考文献7

二级参考文献116

  • 1Jinhua Liu et al.College of Veterinary Medicine, China Agricultural University, Beijing 100094, China..Highly Pathogenic H5N1 Influenza Virus Infection in Migratory Birds[J].中国实验动物学报,2005,13(S1):11-12. 被引量:114
  • 2张杰,徐文方.唾液酸类神经氨酸酶抑制剂的研究进展[J].中国医药工业杂志,2005,36(10):643-647. 被引量:6
  • 3王全英,乔传玲,申之义.禽流感病毒神经氨酸酶的结构及其生物学功能[J].动物医学进展,2005,26(12):40-43. 被引量:14
  • 4Govorkova EA, Leneva IA, Goloubeva OG, et al. Comparison of efficacies of RWJ-270201, zanamivir and oseltamivir against H5N1, H9N2, and other avian influenza viruses[J]. Antimicrob Ag Chemother., 2001,45(10):2723.
  • 5Smee DF, Huffman JH, Morrison AC, et al. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities[J]. Antimicrob Ag Chemother, 2001, 45(3): 743.
  • 6Macdonald S J, Watson KG, Reece PA,et al. Potent and longacting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen.[J]. Antimicrob Ag Chemother, 2004, 48(12):4542.
  • 7李兰娟院士.历史上流感有过几次大规模流行[B].都市快报,2013-04-06.
  • 8Isabelle M, St6phane P, Neil S J, et al. Influenza pathogenesis: Lessons learned from animal studies with H5N1, HIN1 Spanish, and pandemic H1N1 2009 influenza[J]. Critical Care Medicine, 2010, 38:21.
  • 9Beige1 J, Bray M.Current and future antiviral therapy of severe seasonal and avian influenza[J].Antiviral Research 2008, 78:91-102.
  • 10Gubureva LV, Kaiser L, Hayden FG.Influenza virus Neuraminidase(NA) Inhibitor[J]. Lancet, 2000, 355(9206):827.

共引文献40

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部